Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Suboxone SL tablets replaced by SL film in US Sublingual (SL) combination tablets containing buprenorphine and naloxone (Suboxone®; Reckitt Benckiser, Warren, NJ, USA), are being replaced by a sublingual film in the US. The […]
Category: Updates from www.palliativedrugs.com
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics EMA review of cardiovascular safety of NSAIDs The European Medicines Agency (EMA) has finalised a review of recently published information on the cardiovascular safety of non-steroidal anti-inflammatory drugs (NSAIDs). The review confirms the findings […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Latest additions PDF version of PCF4+ now available! An e-book PDF version containing the latest content of the on-line Palliative Care Formulary as of September 2012 (designated PCF4+) is now available to purchase and download from […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Hydromorphone ER 32mg launched in US A once daily modified-release hydromorphone 32mg tablet (Exalgo; Mallinckrodt, Hazelwood, MO) has been added to the existing product range of 8mg, 12mg and 16mg modified-release tablets for opioid-tolerant […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates FDA warn of skin injury with OTC rubefacients Rare cases of serious burns on the skin have been reported to the US Food and Drug Administration (FDA) where over-the-counter (OTC) topical muscle and joint […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics Liverpool Care Pathway consensus statement Over 20 organisations have signed a consensus statement in support of the Liverpool Care Pathway for the dying patient, including professional bodies, third sector organizations, disease specific charities and […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Hot topics DH consultation: Governance arrangements for controlled drugs The Department of Health (DH) is consulting on proposed changes to the governance arrangements for controlled drugs in England and Scotland, including the role and functions of […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Ketamine injection supply problems Pfizer UK has confirmed that there is a supply problem with ketamine (Ketalar) 10mg/mL and 100mg/mL injection. All orders for these products are now being re-directed to a Pfizer central […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates NICE final draft guidance for denosumab The UK National Institute for Health and Clinical Excellence (NICE) has published final draft guidance on the use of denosumab for the treatment of bone metastases from solid tumours […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety updates NPSA insulin passport deadline NHS organisations should ensure that by 31 August 2012 the following actions, outlined in the National Patient Safety Agency (NPSA) alert ‘The adult patient’s passport for safer use of insulin’ (NPSA/2011/PSA003), […]